Insight Molecular Diagnostics

IMDXNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$155.962 M

$4.83 +0.63%

Close of 7 Aug 2026

Revenue

$4.05M

#3340 by revenue

Earnings

-$50.2K

Loss-making

Shares outstanding

32,167,978

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap

All 19 →

#10Alpha TeknovaTKNO$346.3M
#11Myriad GeneticsMYGN$311.8M
#12Insight Molecular DiagnosticsIMDX$156.0M
#13ImmucellICCC$99.5M
#14Q/C TechnologiesQCLS$22.9M

Where these numbers come from

Share counts and financials for Insight Molecular Diagnostics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.